Evidence map›Paper›PMID 38783828›Full record

ArticleCanadian journal of psychiatry. Revue canadienne de psychiatrie2024

Nada Charfi, Amal Bouaziz, Sana Omri, Imen Gassara, Rim Feki, Najeh Smaoui, Lobna Zouari, Mohamed Maâlej, Jihène Ben Thabet, Manel Maâlej Bouali

Abstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Nada CharfiService de Psychiatrie C, CHU Hédi Chaker, Sfax, Tunisie.ORCID 0000-0003-0675-528X
Amal BouazizService de Psychiatrie C, CHU Hédi Chaker, Sfax, Tunisie.
Sana OmriService de Psychiatrie C, CHU Hédi Chaker, Sfax, Tunisie.
Imen GassaraService de Psychiatrie C, CHU Hédi Chaker, Sfax, Tunisie.
Rim FekiService de Psychiatrie C, CHU Hédi Chaker, Sfax, Tunisie.
Najeh SmaouiService de Psychiatrie C, CHU Hédi Chaker, Sfax, Tunisie.
Lobna ZouariService de Psychiatrie C, CHU Hédi Chaker, Sfax, Tunisie.
Mohamed MaâlejService de Psychiatrie C, CHU Hédi Chaker, Sfax, Tunisie.
Jihène Ben ThabetService de Psychiatrie C, CHU Hédi Chaker, Sfax, Tunisie.ORCID 0000-0003-1507-5622
Manel Maâlej BoualiService de Psychiatrie C, CHU Hédi Chaker, Sfax, Tunisie.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesOur aims were to assess cognitive impairment in bipolar patients in remission compared with healthy controls, and to study its connection to clinical and therapeutic factors. METHODOLOGY: This was a case-control study of patients with bipolar disorder (BD) in remission and matched healthy controls. It was carried out at the Hédi Chaker University Hospital in Sfax, Tunisia. The Screen for Cognitive Impairment in Psychiatry (SCIP) scale was used to assess cognitive function in patients and controls. This scale comprises subtests for verbal learning with immediate (VLT-I) and delayed (VLT-D) recall, working memory (WMT), verbal fluency (VFT) and information processing speed (PST).

resultsWe recruited 61 patients and 40 controls. Compared with controls, patients had significantly lower scores on the overall SCIP scale and on all SCIP subtests (

conclusionsOur study showed that bipolar patients in remission presented significantly more marked cognitive impairments, affecting various cognitive domains, than the controls. These cognitive impairments appear to be linked to clinical and therapeutic factors that are themselves considered to be factors of poor prognosis in BD.

Indexed as

Bipolar DisorderCognitive DysfunctionAdultCase-Control StudiesFemaleHumansMaleMiddle AgedNeuropsychological TestsTunisiaBipolar disorderclinical factorscognitive impairmentfacteurs cliniquesremissionrémissiontraitementtreatmenttrouble bipolairetroubles cognitifs

Identifiers

PMID38783828
PMCPMC11351062

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.